Esa Jantunen
Professori, Emeritus
esa.jantunen@uef.fi
Julkaisut
182/182 kappaletta-
Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation
Jantunen, Esa; Turunen, Antti; Varmavuo, Ville; Partanen, Anu. 2024. Transfusion. [Epub ahead of print 26 Feb 2024]: 1-9 -
A retrospective study of treatment results of blood-brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL)
Kuitunen, H; Sonkajärvi, E; Oksman, M; Puhakka, I; Isokangas, M; Pyörälä, M; Jantunen, E; Marin, K; Aromaa-Häyhä, A; Rönkä, A; Auvinen, P; Kuittinen O. 2023. Annals of case reports. 8: -
Blood–Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study
Kuitunen, Hanne K; Rönkä, Aino LK; Sonkajärvi, Eila M; Isokangas, Juha-Matti; Pyörälä, Marja; Palosaari, Kari AA; Jokimäki, Anna S; Partanen, Anu E; Littow, Harri J; Vakkala, Merja A; Jantunen, Esa J; Huttunen, Mirja E; Marin, Katja J; Aromaa-Häyhä, Annikki MK; Auvinen, Päivi K; Selander, Tuomas; Puhakka, Inka K; Kuittinen, Outi M. 2023. Cancers. 15: -
CD34(+) Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients
Turunen, Antti Samuli; Kuittinen, Outi; Kuitunen, Hanne; Vasala, Kaija; Penttila, Karri; Harmanen, Minna; Keskinen, Leena; Mantymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville; Jantunen, Esa; Partanen, Anu. 2023. Transfusion medicine and hemotherapy. 50: 428-437 -
Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data
Rajamäki, Aino; Hujo, Mika; Sund, Reijo; Prusila, Roosa E.I.; Kuusisto, Milla E.L.; Kuitunen, Hanne; Jantunen, Esa; Mercadal, Santiago; Sorigue, Marc; Sancho, Juan Manuel; Sunela, Kaisa; Kuittinen, Outi. 2023. JCO clinical cancer informatics. 7: -
Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation
Partanen, Anu; Turunen, Antti; Valtola, Jaakko; Pyörälä, Marja; Kuittinen, Outi; Kuitunen, Hanne; Vasala, Kaija; Penttilä, Karri; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2023. Clinical lymphoma myeloma and leukemia. 23: e428-e435 -
Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
Jantunen, Esa; Partanen, Anu; Turunen, Antti; Varmavuo, Ville; Silvennoinen, Raija. 2023. Transfusion medicine and hemotherapy. 50: 438-447 -
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria
Harmanen, Minna; Klaavuniemi, Tuula; Sorigue, Marc; Khan, Madiha; Prusila, Roosa; Kari, Esa; Alanne, Erika; Rajamäki, Aino; Sunela, Kaisa; Jukkola, Arja; Jantunen, Esa; Sancho, Juan-Manuel; Ketola, Sanna; Kuitunen, Hanne; Selander, Tuomas; Rönkä, Aino; Kuittinen, Outi. 2023. HemaSphere. 7: -
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
Waszczuk-Gajda, Anna; Penack, Olaf; Sbianchi, Giulia; Koster, Linda; Blaise, Didier; Reményi, Péter; Russell, Nigel; Ljungman, Per; Trneny, Marek; Mayer, Jiri; Iacobelli, Simona; Kobbe, Guido; Scheid, Christof; Apperley, Jane; Touzeau, Cyrille; Lenhoff, Stig; Jantunen, Esa; Anagnostopoulos, Achilles; Paris, Laura; Browne, Paul; Thieblemont, Catherine; Schaap, Nicolaas; Sierra, Jorge; Yakoub-Agha, Ibrahim; Garderet, Laurent; Styczynski, Jan; Schoemans, Helene; Moiseev, Ivan; Duarte, Rafael F.; Pe. 2022. Journal of clinical medicine. 11: -
Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study
Partanen, Anu; Turunen, Antti; Silvennoinen, Raija; Valtola, Jaakko; Pyörälä, Marja; Siitonen, Timo; Sikiö, Anu; Putkonen, Mervi; Sankelo, Marja; Penttilä, Karri; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2022. Journal of clinical apheresis. 2023; 38: 33-44 -
Link between disease status at 24 months and mortality in follicular lymphoma
Rajamäki, Aino; Hujo, Mika; Sund, Reijo; Prusila, Roosa E. I.; Kuusisto, Milla E. L.; Kuitunen, Hanne; Jantunen, Esa; Mercadal, Santiago; Sorigue, Marc; Sancho, Juan‐Manuel; Kuittinen, Outi; Sunela, Kaisa. 2022. British journal of haematology. 199: 458-462 -
Mortality among patients with low‐grade follicular lymphoma: A binational retrospective analysis
Rajamäki, Aino; Hujo, Mika; Sund, Reijo; Prusila, Roosa E. I.; Kuusisto, Milla E. L.; Kuitunen, Hanne; Jantunen, Esa; Mercadal, Santiago; Sorigue, Marc; Sancho, Juan‐Manuel; Sunela, Kaisa; Kuittinen, Outi. 2022. Cancer. 128: 2474-2482 -
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020
Harmanen, Minna; Hujo, Mika; Sund, Reijo; Sorigue, Marc; Khan, Madiha; Prusila, Roosa; Klaavuniemi, Tuula; Kari, Esa; Jantunen, Esa; Sunela, Kaisa; Rajamäki, Aino; Alanne, Erika; Kuitunen, Hanne; Sancho, Juan‐Manuel; Jukkola, Arja; Rönkä, Aino; Kuittinen, Outi. 2022. British journal of haematology. 2023; 201: 64-74 -
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study
Turunen, A; Silvennoinen, R; Partanen, A; Valtola, J; Siitonen, T; Putkonen, M; Sankelo, M; Pyörälä, M; Kuittinen, T; Penttilä, K; Sikiö, A; Savolainen, ER; Mäntymaa, P; Pelkonen, J; Varmavuo,V; Jantunen, E. 2021. Transfusion. 61: 1830-1844 -
Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma
Partanen, Anu; Kuittinen, Outi; Turunen, Antti; Valtola, Jaakko; Pyörälä, Marja; Kuitunen, Hanne; Vasala, Kaija; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2021. Journal of hematology. 10: 246-254 -
Comparison of CD34 + cell mobilization, blood graft cellular composition, and post-transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low-dose cyclophosphamide: A prospective multicenter study
Partanen, Anu; Turunen, Antti; Silvennoinen, Raija; Pyörälä, Marja; Valtola, Jaakko; Siitonen, Timo; Putkonen, Mervi; Sankelo, Marja; Sikiö, Anu; Penttilä, Karri; Kuittinen, Taru; Pelkonen, Jukka; Mäntymaa, Pentti; Jantunen, Esa; Varmavuo, Ville. 2021. Transfusion. 61: 3202-3212 -
Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months
Rajamäki, Aino; Sunela, Kaisa; Prusila, Roosa EI; Kuusisto, Milla EL; Mercadal, Santiago; Selander, Tuomas; Kuitunen, Hanne; Pollari, Marjukka; Jantunen, Esa; Nystrand, Ilja; Sancho, Juan-Manuel; Sorigue, Marc; Kuittinen, Outi. 2021. Leukemia & lymphoma. 62: 1639-1647 -
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study
Lawless, Sarah; Sbianchi, Giulia; Morris, Curly; Iacobelli, Simona; Bosman, Paul; Blaise, Didier; Reményi, Péter; Byrne, J.L.; Mayer, Jiri; Apperley, Jane; Lund, Johan; Kobbe, Guido; Schaap, Nicolaas; Isaksson, Cecilia; Lenhoff, Stig; Basak, Grzegorz; Touzeau, Cyrille; Wilson, Keith M.O.; González Muñiz, Soledad; Scheid, Christof et al. [incl. Jantunen, Esa]. 2021. Clinical lymphoma myeloma and leukemia. 21: 686-693 -
Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia
Intke, C; Korpelainen, S; Lappalainen, M; Vänskä, M; Hämäläinen, S; Pulkki, K; Jantunen, E; Juutilainen, A; Purhonen, AK. 2021. Clinical and experimental medicine. 2022; 22: 83-93 -
A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34+ cells in NHL patients
Partanen, Anu; Turunen, Antti; Valtola, Jaakko; Vasala, Kaija; Ågren, Lasse; Penttilä, Karri; Pyörälä, Marja; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2020. Journal of clinical apheresis. 35: 255-263 -
Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study
Turunen, Antti; Valtola, Jaakko; Partanen, Anu; Ropponen, Antti; Kuittinen, Outi; Kuitunen, Hanne; Vasala, Kaija; Ågren, Lasse; Penttilä, Karri; Keskinen, Leena; Savolainen, Eeva-Riitta; Pyörälä, Marja; Kuittinen, Taru; Selander, Tuomas; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2020. Leukemia & lymphoma. 61: 2082-2092 -
Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34 + cells is associated with improved survival
Partanen, A; Turunen, A; Valtola, J; Pyörälä, M; Vasala, K; Kuittinen, O; Kuitunen, H; Penttilä, K; Kuittinen, T; Mäntymaa, P; Pelkonen, J; Varmavuo, V Jantunen, E. 2020. Leukemia & lymphoma. 61: 3027-3029 -
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter Goa study
Turunen, Antti; Partanen, Anu; Valtola, Jaakko; Ropponen, Antti; Siitonen, Timo; Kuittinen, Outi; Kuitunen, Hanne; Putkonen, Mervi; Sankelo, Marja; Keskinen, Leena; Savolainen, Eeva-Riitta; Pyörälä, Marja; Kuittinen, Taru; Silvennoinen, Raija; Penttilä, Karri; Sikiö, Anu; Vasala, Kaija; Mäntymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville; et al.. 2020. Transfusion. 60: 1519-1528 -
Febrile neutropenia in patients with acute myeloid leukemia: outcome in relation to qSOFA score, C-reactive protein and blood culture findings
Lappalainen, Marika; Hämäläinen, Sari; Romppanen, Tuomo; Pulkki, Kari; Pyörälä, Marja; Koivula, Irma; Jantunen, Esa; Juutilainen, Auni. 2020. European journal of haematology. 105: 731-740 -
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma
Kuitunen, H; Kaprio, E; Karihtala, P; Makkonen, V; Kauppila, S; Haapasaari, KM; Kuusisto, M; Jantunen, E; Turpeenniemi-Hujanen, T; Kuittinen, O. 2020. Annals of hematology. 99: 1823-1831 -
Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study
Partanen, Anu; Turunen, Antti; Valtola, Jaakko; Pyörälä, Marja; Vasala, Kaija; Kuittinen, Outi; Kuitunen, Hanne; Penttilä, Karri; Keskinen, Leena; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville; Jantunen, Esa. 2020. Transfusion. 2021; 61: 516-525 -
Plasma level of interleukin-18 and complicated course of febrile neutropenia in hematological patients after intensive chemotherapy
Korpelainen, Sini; Hämäläinen, Sari; Vänskä, Matti; Koivula, Irma; Pulkki, Kari; Jantunen, Esa; Juutilainen, Auni; Purhonen, Anna-Kaisa. 2020. Cytokine. 129: 155021 -
Pleriksafori kantasolujen mobilisaatiossa autologista siirtoa varten
Jantunen, Esa; Valtola, Jaakko; Partanen, Anu; Turunen, Antti; Kuittinen, Taru; Silvennoinen, Raija; Pyörälä, Marja; Mäntymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville. 2020. Duodecim. 136: 997-1004 -
Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas
Uotila, PM; Lemma, SA; Haapasaari, KM; Porvari, K; Skarp, S; Soini, Y; Jantunen, E; Turpeenniemi-Hujanen, T; Kuittinen, O. 2020. Hematology. 25: 241-246 -
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor
Sureda, A; Chabannon, C; Masszi, T; Pohlreich, D; Scheid, C; Thieblemont, C; Wahlin, BE; Sakellari, I; Russell, N; Janikova, A; Dabrowska-Iwanicka, A; Touzeau, C; Esquirol, A; Jantunen, E; van der Werf, S; Bosman, P; Boumendil, A; Liu, Q; Celanovic, M; Montoto, S; et al.. 2019. Bone marrow transplantation. 2020; 55: 613-622 -
Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry
Alexander, T; Samuelson, C; Daikeler, T; Henes, J; Akil, M; Skagerlind, L; Ehninger, G; Jantunen, E; Badoglio, M; Farge, D; Snowden, JA; on behalf of the BMT Autoimmune Diseases Working Party. 2019. Bone marrow transplantation. [Published 17 December 2019]: 1-4 -
Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients
Jantunen, Esa; Varmavuo, Ville; Pelkonen, Jukka; Valtola, Jaakko. 2019. Leukemia & lymphoma. 60: 2115-2121 -
Incidence of solid cancer in patients with follicular lymphoma
Sorigue, M; Prusila, REI; Jauhiainen, J; Mercadal, S; Postila, A; Salmi, P; Tanhua, T; Tikkanen, S; Kakko, S; Kuitunen, H; Pollari, M; Nystrand, I; Kuusisto, MEL; Vasala, K; Jantunen, E; Korkeila, E; Karihtala, P; Sancho, JM; Turpeenniemi-Hujanen, T; Kuittinen, O. 2019. Acta oncologica. 58: 1564-1569 -
MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia
Becker, S; Korpelainen, S; Arvonen, M; Hämäläinen, S; Jantunen, E; Lappalainen, M; Pulkki, K; Riikonen, P; Juutilainen, A. 2019. Leukemia & lymphoma. 60: 3036-3043 -
Monimuotoinen myelooma
Säily, Marjaana; Silvennoinen, Raija; Jantunen, Esa; Anttila, Pekka; Lievonen, Juha; Putkonen, Mervi. 2019. Duodecim. 135: 1171-1179 -
Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP
Kari, E; Teppo, HR; Haapasaari, KM; Kuusisto, MEL; Lemma, A; Karihtala, P; Pirinen, R; Soini, Y; Jantunen, E; Turpeenniemi-Hujanen, T; Kuittinen, O. 2019. Journal of clinical pathology. 72: 316-321 -
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy: A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
González-Barca; E; Boumendil, A; Blaise, D; Trnený, M; Masszi, T; Finel, H; Michieli, MG; Bittenbring, JT; Gritti, G; Snowden, JA; Bishton, M; Bruno, B; de Villambrosia, SG; Janikova, A; Leleu, X; Anagnostopoulos, A; Poiré, X; Crysandt, M; Özkurt, ZN; Vandenberghe, E; et al. [incl. Jantunen, E]. 2019. Bone marrow transplantation. 2020; 55: 393-399 -
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group
Luoma, S; Anttila, P; Säily, M; Lundan, T; Heiskanen, J; Siitonen, T; Kakko, S; Putkonen, M; Ollikainen, H; Terävä, V; Sankelo, M; Partanen, A; Launonen, K; Räsänen, A; Sikiö, A; Suominen, M; Bazia, P; Kananen, K; Lievonen, J; Selander, T; et al. [incl. Mäntymaa, P; Jantunen, E]. 2019. Annals of hematology. 98: 2781-2792 -
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era
Prusila, REI; Sorigue, M; Jauhiainen, J; Mercadal, S; Postila, A; Salmi, P; Tanhua, T; Tikkanen, S; Kakko, S; Kuitunen, H; Pollari, M; Nystrand, I; Kuusisto, MEL; Vasala, K; Jantunen, E; Korkeila, E; Karihtala, P; Sancho, JM; Turpeenniemi-Hujanen, T; Kuittinen, O. 2019. British journal of haematology. 187: 364-371 -
Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study
Valtola, J; Silvennoinen, R; Ropponen, A; Siitonen, T; Säily, M; Sankelo, M; Putkonen, M; Partanen, A; Pyörälä, M; Savolainen, ER; Mäntymaa, P; Pelkonen, J; Jantunen, E; Varmavuo, V. 2018. Leukemia & lymphoma. 2019; 60: 453-461 -
Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients
Rönkkö, Rosa; Juutilainen, Auni; Koivula, Irma; Vänskä, Matti; Nousiainen, Tapio; Jantunen, Esa; Hämäläinen, Sari. 2018. Infectious diseases. 50: 436-442 -
Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients
Partanen, A; Valtola, J; Ropponen, A; Kuitunen, H; Kuittinen, O; Vasala, K; Ågren, L; Penttilä, K; Keskinen, L; Pyörälä, M; Nousiainen, T; Selander, T; Mäntymaa, P; Pelkonen, J; Varmavuo, V; Jantunen, E. 2018. Transfusion. 2019; 59: 325-334 -
Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients
Intke, Carina; Korpelainen, Sini; Hämäläinen, Sari; Vänskä, Matti; Koivula, Irma; Jantunen, Esa; Pulkki, Kari; Juutilainen, Auni. 2018. European journal of haematology. 101: 691-698 -
Melphalan 140 mg/m2 or 200 mg/m2 for autologous trasnplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party
Auner, Holger W; Iacobelli, Simona; Sbianchi, Giulia; Knol-Bout, Cora; Blaise, Didier; Russell, Nigel H; Apperley, Jane F; Pohlreich, David; Browne, Paul V; Kobbe, Guido; Isaksson, Cecilia; Lenhoff, Stig; Scheid, Christof; Touzeau, Cyrille; Jantunen, Esa; Anagnostopoulos, Achilles; Yakoub-Agha, Ibrahim; Tanase, Alina; Schaap, Nicolaas; Wiktor-Jedrzejczak, Wieslaw; et al.. 2018. Haematologica: the hematology journal. 103: 514-521 -
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
Peroja, P; Pedersen, M; Mantere, T; Nørgaard, P; Peltonen, J; Haapasaari, KM; Böhm, J; Jantunen, E; Turpeenniemi-Hujanen, T; Rapakko, K; Karihtala, P; Soini, Y; Vasala, K; Kuittinen, O. 2018. Scientific reports. 8: 14814 -
Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics
Lappalainen, Marika; Jokkala, Jenna; Juutilainen, Auni; Hämäläinen, Sari; Koivula, Irma; Jantunen, Esa; Hanhineva, Kati; Pulkki, Kari. 2018. Disease markers. 2018: 6964529 -
Treatment of Diffuse Large B-cell Lymphoma in Elderly Patients: Replacing Doxorubicin with either Epirubicin or Etoposide (VP-16)
Prusila, Roosa; Peroja, Pekka; Jantunen, Esa; Turpeenniemi-Hujanen, Taina; Kuittinen Outi. 2018. Hematological oncology. 2019; 37: 136-142 -
Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients
Lappalainen Marika, Hämäläinen Sari, Juutilainen Auni, Koivula Irma, Pulkki Kari, Jantunen Esa. 2017. Scandinavian journal of clinical and laboratory investigation. 77: 130-134 -
Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: A prospective comparison
Valtola Jaakko, Varmavuo Ville, Ropponen Antti, Nihtinen Anne, Partanen Anu, Vasala Kaija, Lehtonen Päivi, Penttilä Karri, Pyörälä Marja, Kuittinen Taru, Silvennoinen Raija, Nousiainen Tapio, Pelkonen Jukka, Mäntymaa Pentti, Jantunen Esa. 2015. Transfusion. 55: 2358-2368 -
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study
Harjama Liisa, Kuitunen Hanne, Turpeenniemi-Hujanen Taina, Haapasaari Kirsi Maria, Leppä Sirpa, Mannisto Susanna, Karjalainen-Lindsberg Marja-Liisa, Lehtinen Tuula, Eray Mine, Vornanen Martine, Haapasalo Hannu, Soini Ylermi, Jantunen Esa, Nousiainen Tapio, Vasala Kaija, Kuittinen Outi. 2015. Acta oncologica. 54: 939-943 -
High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index
Kuusisto Milla Elvi Linnea, Haapasaari Kirsi-Maria, Turpeenniemi-Hujanen Taina, Jantunen Esa, Soini Ylermi, Peroja Pekka, Bloigu Risto, Karihtala Peeter, Kuittinen Outi. 2015. Journal of clinical pathology. 68: 552-556 -
Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients
Purhonen Anna-Kaisa, Juutilainen Auni, Vänskä Matti, Lehtikangas Maija, Lakkisto Päivi, Hämäläinen Sari, Koivula Irma, Jantunen Esa, Pulkki Kari. 2015. Infectious diseases. 47: 255-259 -
Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study
Lemma Siria A, Pasanen Anna Kaisa, Haapasaari Kirsi-Maria, Sippola Antti, Sormunen Raija, Soini Ylermi, Jantunen Esa, Koivunen Petri, Salokorpi Niina, Bloigu Risto, Turpeenniemi-Hujanen Taina, Kuittinen Outi. 2015. European journal of haematology. [epub ahead of print 7 AUG 2015]: - -
Epäselvä kuumeilu, suurentunut plasman ferritiinipitoisuus ja nopeasti kehittynyt monielinvaurio
Jantunen E, Siitonen S, Karjalainen-Lindsberg M-L. 2014. Duodecim. 130: 269-277 -
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
Kolstad Arne, Laurell Anna, Jerkeman Mats, Grønbæk Kirsten, Elonen Erkki, Räty Riikka, Pedersen Lone Bredo, Loft Annika, Bogsrud Trond Velde, Kimby Eva, Hansen Per Boye, Fagerli Unn-Merete, Nilsson-Ehle Herman, Lauritzsen Grete Fossum, Lehmann Anne Kristine, Sundstrom Christer, Karjalainen-Lindsberg Marja-Liisa, Ralfkiaer Elisabeth, Ehinger Mats, Delabie Jan et al (including Jantunen Esa). 2014. Blood. 123: 2953-2959 -
Plerixafor for mobilization of blood stem cells in autologous transplantation: an update
Jantunen E, Varmavuo V. 2014. Expert opinion on biological therapy. 14: 851-861 -
Spermidine/spermine N1-acetyltransferase activity associates with white blood cell count in myeloid leukemias
Pirnes-Karhu Sini, Jantunen Esa, Mäntymaa Pentti, Mustjoki Satu, Alhonen Leena, Uimari Anne. 2014. Experimental hematology. 42: 574-580 -
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT
Jantunen E, Boumendil A, Finel H, Luan JJ, Johnson P, Rambaldi A, Haynes A, Duchosal MA, Bethge W, Biron P, Carlson K, Craddock C, Rudin C, Finke J, Salles G, Kroschinsky F, Sureda A, Dreger P on behalf of Lymphoma Working Party of the EBMT.. 2013. Blood. 121: 2529-2532 -
Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma
Lemma S, Karihtala P, Haapasaari KM, Jantunen E, Soini Y, Bloigu R, Pasanen AK, Turpeenniemi-Hujanen T, Kuittinen O.. 2013. Histopathology. 62: 326-333 -
CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients
Varmavuo V, Mäntymaa P, Silvennoinen R, Nousiainen T, Kuittinen T, Jantunen E. 2013. Transfusion. 53: 1024-1032 -
Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy
Pasanen AK, Haapasaari KM, Peltonen J, Soini Y, Jantunen E,. 2013. European journal of haematology. 91: 29-36 -
Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients
Varmavuo V, Rimpiläinen J, Kuitunen H, Nihtinen A, Vasala K, Mikkola M, Kutila A, Lehtonen P, Kuittinen T, Mäntymaa P, Nousiainen T, Kuittinen O, Jantunen E. 2013. Bone marrow transplantation -
Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.
Varmavuo V, Rimpiläinen J, Kuitunen H, Nihtinen A, Vasala K, Mikkola M, Kutila A, Lehtonen P, Kuittinen T, Mäntymaa P, Nousiainen T, Kuittinen O, Jantunen E. 2013. Transfusion. e-pub: e-pub -
Enhanced polyamine catabolism disturbs hematopoietic lineage commitment and leads to a myeloproliferative disease in mice overexpressing spermidine/spermine N 1-acetyltransferase
Pirnes-Karhu S, Mäntymaa P, Sironen R, Mäkinen PI, Wojciechowski S, Juutinen S, Koistinaho J, Hörkkö S, Jantunen E, Alhonen L, Uimari A. 2013. Amino acids. 2013 Jul 9. [Epub ahead of print]: - -
Graft and outcome in autologous stem cell transplantation: a prospective GOA study
Jantunen E, Ropponen A, Siitonen T, Niittyvuopio R, Sankelo M, Putkonen M, Varmavuo V, Pyörälä M, Kuittinen T, Silvennoinen R, Kutila A, Nihtinen A, Vasala K, Lehtonen P, Sikiö A, Valonen P, Nousiainen T, Pelkonen J, Mäntymaa P. 2013. Bone marrow transplantation -
Is autologous stem cell transplantation feasible in solid organ transplant recipients with non-Hodgkin's lymphoma?
Jantunen E, Pyörälä M, Kuittinen T, Mäntymaa P, Koljonen E, Kuittinen O, Kuitunen H, Nousiainen T. 2013. Bone marrow transplantation -
New insight into mechanisms of myeloproliferative disorders
Alhonen L, Pirnes-Karhu A, Uimari A, Jantunen E, Mäntymaa P, Määttä J, Finnilä M, Mustajoki S. 2013. Febs journal -
Soluble form of urokinase-type plasminogen activator receptor as a diagnostic and prognostic marker in hematological patients with neutropenic fever
Vänskä M, Purhonen AK, Koivula I, Jantunen E, Hämäläinen S, Pulkki K, Juutilainen A.. 2013. Leukemia & lymphoma. 2013 Jul 22: 1-2 -
A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy
Sipola P, Vanninen E, Jantunen E, Nousiainen T, Kiviniemi M, Hartikainen J, Kuittinen T. 2012. Nuclear medicine communications. 33: 51-59 -
Aikuisten immunologinen trombosytopenia - mitä uutta?
Jantunen E, Ruottinen S, Kuittinen T, Nousiainen T. 2012. Lääkärilehti. 67: 1416-1419 -
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
Jantunen E, Canals C, Attal M, Thomson K, Milpied N, Buzyn A, Ferrant A, Biron P, Crawley C, Schattenberg A, Luan JJ, Tilly H, Rio B, Wijermans PW, Dreger P, Sureda A; Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT). 2012. Annals of oncology. 23: 166-171 -
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT).
Jantunen E, Canals C, Attal M, Thomson K, Milpied N, Buzyn A, Ferrant A, Biron P, Crawley C, Schattenberg A, Luan JJ, Tilly H, Rio B, Wijermans PW, Dreger P, Sureda A, Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT).. 2012. Annals of oncology. 23: 166-171 -
Blood graft composition after plerixafor injection in NHL patients
Varmavuo V, Mäntymaa P, Nousiainen T, Valonen P, Kuittinen T, Jantunen E, Valonen P. 2012. European journal of haematology. 89: 128-135 -
Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor
Varmavuo V, Mäntymaa P, Kuittinen T, Nousiainen T, Jantunen E. 2012. Transfusion. 52: 1785-1791 -
Comparison of Post-Transplant Outcomes in Non-Hodgkin Lymphoma (NHL) Patients Mobilized with or without Plerixafor Added to Chemomobilization
Varmavuo V, Rimpiläinen J, Nihtinen A, Vasala K, Mikkola M, Lehtonen P, Kuittinen T, Mäntymää P, Nousiainen T, Kuittinen O, Jantunen E. 2012. Blood. 120: Abstract 4520 -
Comparison of blood graft cellular content in myeloma (MM) patients and non-hodgkin lymphoma (NHL) patients mobilized with chemotherapy plus G-CSF with or without plerixafor
Jantunen E, Varmavuo V, Silvennoinen R, Valonen P, Kuittinen T, Nousiainen T, Mäntymaa P. 2012. Blood. 120: Abstract 4414 -
High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry
Mounier N, Canals C, Gisselbrecht C, Cornelissen J, Foa R, Conde E, Maertens J, Attal M, Rambaldi A, Crawley C, Luan JJ, Brune M, Wittnebel S, Cook G, van Imhoff GW, Pfreundschuh M, Sureda A, for the Lymphoma Working Party of the European Blood and Marrow Transplantation Registry (EBMT). 2012. Biology of blood and marrow transplantation. 18: 788-793 -
IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M, Koivula I, Jantunen E, Hämäläinen S, Purhonen AK, Pulkki K, Juutilainen A.. 2012. Cytokine. 2012 Dec;60: 787-92 -
Kinetics of blood CD34+ cells after chemotherapy plus G-CSF in poor mobilizers: implications for pre-emptive plerixafor use
Jantunen E, Varmavuo V, Juutilainen A, Kuittinen T, Mahlamäki E, Mäntymaa P, Nousiainen T. 2012. Annals of hematology. 91: 1073-1079 -
Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma
Peroja P, Pasanen A K, Haapasaari K-M, Jantunen E, Soini Y, Turpeenniemi-Hujanen T, Bloigu R, Lilja L, Kuittinen O, Karihtala P. 2012. Experimental hematology & oncology. 1: 2 -
Plasma copeptin in the assessment of febrile neutropenia.
Purhonen AK, Vänskä M, Hämäläinen S, Pulkki K, Lehtikangas M, Kuittinen T, Nousiainen T, Koivula I, Jantunen E, Juutilainen A. 2012. Peptides. 36: 129-132 -
Pre-emptive plerixafor injection increases blood neutrophil, lymphocyte and monocyte counts in addition to CD34+ counts in patients with non-Hodgkin lymphoma mobilizing poorly with chemotherapy plus G-CSF: potential implications for apheresis and graft composition
Varmavuo V, Mäntymaa P, Kuittinen T, Nousiainen T, Jantunen E. 2012. Transfusion and apheresis science. 46: 257-262 -
Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept
Jantunen E, Lemoli RM. 2012. Transfusion. 52: 906-914 -
Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer's disease
Magga J, Savchenko E, Malm T, Rolova T, Pollari E, Valonen P, Lehtonen S, Jantunen E, Aarnio J, Lehenkari P, Koistinaho M, Muona A, Koistinaho J. 2012. Journal of cellular and molecular medicine. 2012 May;16(5): 1060-73 -
Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group.
Räty R, Honkanen T, Jantunen E, Jyrkkiö S, Karjalainen-Lindsberg ML, Kuittinen O, Lehto M, Mikkola M, Poikonen E, Rauhala A, Rimpiläinen J, Räsänen A, Siitonen S, Suominen M, Vapaatalo M, Elonen E.. 2012. Leukemia & lymphoma. 53: 1920-1928 -
The evolving role of stem cell transplants in lymphomas
Jantunen E, Sureda A. 2012. Biology of blood and marrow transplantation. 18: 660-673 -
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Osterborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Ostenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE. 2012. Journal of clinical oncology. 30: 3093-3099 -
Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients
Jantunen E, Penttilä K, Pyörälä M, Mahlamäki E, Kuittinen T, Nousiainen T. 2011. Bone marrow transplantation. 46: 308-309 -
Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis
Juutilainen A, Hämäläinen S, Pulkki K, Kuittinen T, Nousiainen T, Jantunen E, Koivula I. 2011. Leukemia & lymphoma. 52: 2349-2355 -
Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience
Jantunen E, Kuittinen T, Mahlamäki E, Pyörälä M, Mäntymaa P, Nousiainen T. 2011. European journal of haematology. 86: 299-304 -
Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia
Koivula I, Hämäläinen S, Jantunen E, Pulkki K, Kuittinen T, Nousiainen T, Juutilainen A. 2011. Scandinavian journal of infectious diseases. 43: 471-478 -
High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients
Vänskä Matti, Koivula Irma, Hämäläinen Sari, Pulkki Kari, Nousiainen Tapio, Jantunen Esa, Juutilainen Auni. 2011. Haematologica: the hematology journal. 96: 1385-1389 -
Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimens
Jantunen E, Fruehauf S. 2011. Bone marrow transplantation. 46: 627-635 -
Novel blood stem cell mobilization strategies: special focus on plerixafor
Jantunen E. 2011. Expert opinion on biological therapy. 11: 1241-1248 -
Novel strategies for blood stem cell mobilization: special focus on plerixafor
Jantunen Esa. 2011. Expert opinion on biological therapy. 11: 1241-1248 -
Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy
Juutilainen A, Vänskä M, Pulkki K, Hämäläinen S, Nousiainen T, Jantunen E, Koivula I. 2011. European journal of haematology. 87: 441-447 -
Serum cortisol and inflammatory response in neutropenic fever
Juutilainen A, Hämäläinen S, Niemenpää J, Kuittinen T, Pulkki K, Koivula I, Niskanen L, Jantunen E. 2011. Annals of hematology. 90: 1467-1475 -
Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters
Syrjälä H, Ohtonen P, Kinnunen U, Räty R, Elonen E, Nousiainen T, Jantunen E, Remes K, Itälä-Remes M, Silvennoinen R, Koistinen P, Finnish Leukemia Group. 2010. Journal of infectious diseases. 29: 1211-1218 -
Fibrinogen and antithrombin in hematological patients with neutropenic fever
Matinlauri I, Juutilainen A, Hämäläinen S, Koivula I, Kuittinen T, Jantunen E. 2010. Central european journal of medicine. 5: 520-526 -
Late potentials and QT dispersion after high-dose chemotherapy in patients with non-Hodgkin lymphoma
Kuittinen T, Jantunen E, Vanninen E, Mussalo H, Nousiainen T, Hartikainen J. 2010. Clinical physiology and functional imaging. 30: 175-180 -
Lymfoomapotilaiden allogeeniset kantasolujen sirrot
Jantunen E, Jyrkkiö S, Kuittinen T, Lehtinen T, Janes R, Elonen E, Volin L. 2010. Duodecim. 126: 167-173 -
Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies
Jantunen E, Kvalheim G. 2010. European journal of haematology. 85: 463-471 -
Myeloomapotilaiden uudet lääkkeet
Jantunen E. 2010. Lääkärilehti. 65: 3971-3976 -
Plasma fibrinogen and antithrombin in haematological patients with neutropenic fever
Matinlauri I, Juutilainen A, Hämäläinen S, Koivula I, Kuittinen T, Jantunen E. 2010. Central european journal of medicine. 5: 520-526 -
Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy
Taskinen Minna, Jantunen Esa, Kosma Veli-Matti, Bono Petri, Karjalainen-Lindsberg Marja-Liisa, Leppä Sirpa. 2010. European journal of cancer. 46: 2506-2512 -
Serial plasma lactate measurements in haematological patients with neutropenic fever
Juutilainen A, Hämäläinen A, Matinlauri I, Kuittinen T, Nousiainen T, Pulkki K, Koivula I, Jantunen E. 2010. Scandinavian journal of infectious diseases. 42: 102-108 -
Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein
Hämäläinen S, Juutilainen A, Kuittinen T, Nousiainen T, Matinlauri I, Pulkki K, Koivula I, Jantunen E. 2010. Leukemia & lymphoma. 51: 1040-1046 -
Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein
Hämäläinen S, Juutilainen A, Matinlauri I, Kuittinen T, Ruokonen E, Koivula I, Jantunen E. 2009. European journal of haematology. 83: 251-257 -
Severe sepsis in autologous stem cell transplant recipients: Microbiological aetiology, risk factors and outcome
Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E. 2009. Scandinavian journal of infectious diseases. 41: 14-20 -
Acute lymphoblastic leukemia in adolescents and young adults in Finland
Usvasalo A, Räty R, Knuutila S, Vettenranta K, Harila-Saari A, Jantunen E, Kauppila M, Koistinen P, Parto K, Riikonen P, Salmi TT, Silvennoinen R, Elonen E, Saarinen-Pihkala UM. 2008. Haematologica: the hematology journal. 93: 1161-1168 -
Aikuispotilaiden autologiset kantasolusiirrot
Jantunen E. 2008. Lääkärilehti. 63: 1171-1177 -
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry
Jantunen E, Canals C, Rambaldi A, Ossenkoppele G, Allione B, Blaise D, Conde E, Tilly H, Cook G, Clark F, Gallamini A, Haynes A, Mounier N, Dreger P, Pfreundschuh M, Sureda A, the EBMT Lymphoma Working Party. 2008. Haematologica: the hematology journal. 93: 1837-1842 -
Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis
Jantunen E, Itälä M, Siitonen T, Kuittinen T, Heiskanen J, Koivunen E, Juvonen E, Silvennoinen R, Nousiainen T, Koistinen P, Volin L, Remes K. 2008. Bone marrow transplantation. 41: 239-244 -
Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues
Jantunen E, Kuittinen T. 2008. European journal of haematology. 80: 287-295 -
Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients
Jantunen E, Nihtinen A, Anttila V-J. 2008. Transplant infectious disease. 10: 156-161 -
Diffuusin suurisoluisen B-solulymfooman hoito
Leppä S, Elonen E, Jantunen E, Jyrkkiö S, Karjalainen-Lindsberg M-L, Kuittinen O, Vasala K, Lehtinen T. 2008. Lääkärilehti. 63: 7-15 -
Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma
Nyman H, Jantunen E, Juvonen E, Elonen E, Böhm J, Kosma V-M, Enblad G, Karjalainen-Lindsberg M-L, Leppä S. 2008. Bone marrow transplantation. 42: 93-98 -
Iäkkäiden potilaiden pahanlaatuisten veritautien hoito
Jantunen E, Kuittinen T, Elonen E. 2008. Duodecim. 124: 2181-2188 -
Myelooman muuttuva hoito
Jantunen E. 2008. Duodecim. 124: 59-66 -
Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences
Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E. 2008. Leukemia & lymphoma. 49: 495-501 -
Follikulaarisen lymfooman hoito
Jyrkkiö S, Jantunen E, Keskinen L, Kuittinen O, Leppä S, Vasala K, Vornanen M, Lehtinen T. 2007. Lääkärilehti. 62: 1729-1733 -
Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a
Daikeler T, Kötter I, Bocelli Tyndall C, Apperley J, Attarbaschi A, Guardiola P, Gratwohl A, Jantunen E, Marmont A, Porretto F, Musso M, Maurer B, Rinaldi N, Saccardi R, Tyndall A, for the EBMT Autoimmune Diseases Working Party,. 2007. Annals of the rheumatic diseases. 66: 202-207 -
Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group
Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T, Pelliniemi T-T, Remes K, Ruutu T, Savolainen E-R, Siitonen T, Silvennoinen R, Volin L, Elonen E, for the Finnish Leukaemia Group. 2007. European journal of haematology. 78: 477-486 -
Mukosiitti - syövän hoidon merkittävä pulma
Jantunen E, Kataja V. 2007. Lääkärilehti. 62: 1243-1247 -
Anagrelidi krooniseen myeloproliferatiiviseen tautiin liittyvän trombosytoosin hoidossa
Jantunen E, Penttilä K, Kuittinen T, Nousiainen T. 2006. Duodecim. 122: 453-457 -
Autologous stem cell transplantation beyond 60 years of age
Jantunen E. 2006. Bone marrow transplantation. 38: 715-720 -
Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience
Jantunen E, Itälä M, Siitonen T, Juvonen E, Koivunen E, Koistinen P, Volin L, Remes K, Nousiainen T. 2006. Bone marrow transplantation. 37: 1093-1098 -
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation
Kuittinen T, Jantunen E, Vanninen E, Mussalo H, Vuolteenaho O, Ala-Kopsala M, Nousiainen T, Hartikainen J. 2006. European journal of haematology. 77: 120-127 -
Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients
Jantunen E, Itälä M, Lehtinen T, Kuittinen O, Koivunen E, Leppä S, Juvonen E, Koistinen P, Wiklund T, Nousiainen T, Remes K, Volin L. 2006. European journal of haematology. 76: 245-250 -
High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients on the same protocol
Jantunen E, Kuittinen T, Penttilä K, Lehtonen P, Mahlamäki E, Nousiainen T. 2006. Bone marrow transplantation. 37: 917-922 -
Autologous stem cell transplantation in patients with high-risk plasmacytoma
Jantunen E, Koivunen E, Putkonen M, Siitonen T, Juvonen E, Nousiainen T. 2005. European journal of haematology. 74: 402-406 -
Outcome of progressive disease after autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a nation-wide survey
Kuittinen T, Wiklund T, Remes K, Elonen E, Lehtinen T, Kuittinen O, Leppä S, Putkonen M, Räty R, Turpeenniemi-Hujanen T, Nousiainen T, Jantunen E. 2005. European journal of haematology. 75: 199-205 -
Perifeeriset T-solulymfoomat
Jantunen E, Vornanen M. 2005. Duodecim. 60: 3611-3617 -
Stem cell transplantation in autoimmune diseases: an uptake
Jantunen E, Luosujärvi R. 2005. Annals of medicine. 37: 533-541 -
Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation
Kuittinen T, Husso-Saastamoinen M, Sipola P, Vuolteenaho O, Ala-Kopsala M, Nousiainen T, Jantunen E, Hartikainen J. 2005. Bone marrow transplantation. 36: 1077-1082 -
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR
Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar JM, Verburg R, Szer J, Taylor K, Joske D, Rule S, Bingham SJ, Emery P, Burt RK, Lowenthal RM, Durez P, McKendry RJ, Pavletic SZ, Espigado I, Jantunen E, Kashyap A, Rabusin M, Brooks P, Bredeson C, Tyndall A. 2004. Journal of rheumatology. 31: 482-488 -
Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey
Jantunen E, Wiklund T, Juvonen E, Putkonen M, Lehtinen T, Kuittinen O, Franssila K, Söderström K-O, Leppä S, Elonen E, Remes K, Nousiainen T. 2004. Bone marrow transplantation. 33: 405-410 -
Autologous stem cell transplantation in patients with primary amyloidosis: a nation-wide survey
Jantunen E, Siitonen T, Putkonen M, Koivunen E, Juvonen E, Nousiainen T, Koistinen P. 2004. Leukemia & lymphoma. 45: 2485-2489 -
Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis
Jantunen E, Nihtinen A, Volin L, Juvonen E, Parkkali T, Ruutu T, Anttila V-J. 2004. Bone marrow transplantation. 34: 891-895 -
Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients
Jantunen E, Salonen J, Juvonen E, Koivunen E, Siitonen T, Lehtinen T, Kuittinen O, Leppä S, Anttila V-J, Itälä M, Wiklund T, Remes K, Nousiainen T. 2004. European journal of haematology. 73: 174-178 -
Maha-suolikanavan lymfoomat
Vornanen M, Heikkinen M, Jantunen E. 2004. Duodecim. 120: 1859-1865 -
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle
Ruutu T, Koivunen E, Nousiainen T, Pelliniemi T-T, Almqvist A, Anttila P, Jantunen E, Koistinen P, Koponen A, Mikkola M, Oksanen K, Pulli T, Remes K, Sarkkinen R, Silvennoinen R, Timonen T, Vanhatalo S, Elonen E, for the Finnish Leukaemia Group. 2004. European journal of haematology. 72: 38-44 -
Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma
Kuittinen T, Nousiainen T, Halonen P, Mahlamäki E, Jantunen E. 2004. Bone marrow transplantation. 33: 907-912 -
Primaarit luulymfoomat. KYS:n kokemukset 1990-2003
Jantunen E, Kettunen J, Niemitukia L, Ropponen K, Vornanen M, Voutilainen L, Mussalo H, Nousiainen T. 2004. Duodecim. 120: 2681-2687 -
Stem cell transplantation for peripheral T-cell lymphomas
Jantunen E, D¿Amore F. 2004. Leukemia & lymphoma. 45: 441-446 -
BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy
Jantunen E, Kuittinen T, Nousiainen T. 2003. Leukemia & lymphoma. 44: 1151-1158 -
Central nervous system aspergillosis in allogeneic stem cell transplant resipients
Jantunen E, Volin L, Salonen O, Piilonen A, Parkkali T, Anttila V-J, Paetau A, Ruutu T. 2003. Bone marrow transplantation. 31: 191-196 -
High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma
Jantunen E, Juvonen E, Wiklund M, Putkonen M, Nousiainen T. 2003. Leukemia & lymphoma -
Is chemotherapy scoring useful to predict progenitor cell mobilisation in patient with non-Hodgkin`s lymphoma?
Jantunen E, Kuittinen T, Nousiainen T. 2003. Bone marrow transplantation. 32: 569-573 -
Low-dose or intermediate-dose cyclophoshamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma
Jantunen E, Putkonen M, Nousiainen T, Pelliniemi T-T, Mahlamäki E, Remes K. 2003. Bone marrow transplantation. 31: 347-351 -
A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeoloma patients
Jantunen E, Kuittinen T, Nousiainen T. 2002. Leukemia & lymphoma. 43: 1961-1965 -
Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
Jantunen E, Anttila V-J, Ruutu T. 2002. Bone marrow transplantation. 30: 925-929 -
Autologous stem cell transplantation in patients with mantle cell lymphoma
Oinonen R, Jantunen E, Itälä M, Lehtinen T, Kuittinen O, Franssila K, Wiklund T, Elonen E. 2002. Leukemia & lymphoma. 43: 1229-1237 -
Bisphosphonate therapy in multiple myeloma: past, present, future
Jantunen E. 2002. European journal of haematology. 69: 257-264 -
Concomitant impairment of left ventricular systolic and diastolic function during doxorubicin therapy: A prospective radionuclide ventriculographic and echocardiographic study
Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, Hartikainen J. 2002. Leukemia & lymphoma. 43: 1807-1811 -
Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients
Nousiainen T, Jantunen E, Vanninen E, Hartikainen J. 2002. British journal of cancer. 86: 1697-1700 -
Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction
Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, Vuolteenaho O, Hartikainen J. 2002. Journal of internal medicine. 251: 228-234 -
Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients
Jantunen E, Piilonen A, Volin L, Ruutu P, Parkkali T, Koukila-Kähkölä P, Ruutu T. 2002. Bone marrow transplantation. 29: 353-356 -
Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake
Nousiainen T, Vanninen E, Jantunen E, Remes J, Kuikka J, Hartikainen J. 2001. Clinical physiology and functional imaging. 21: 123-128 -
Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy
Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, Hartikainen J. 2001. Journal of internal medicine. 249: 297-303 -
Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients
Nousiainen T, Vanninen E, Jantunen E, Remes J, Ritanen E, Vuolteenaho O, Hartikainen J. 2001. Clinical science. 101: 601-607 -
Hospital water supply as a source of disseminated Mycobacterium fortuitum infection in a leukemia patient
Kauppinen J, Nousiainen T, Jantunen E, Mattila R, Katila M-L. 1999. Infection control and hospital epidemiology. 20: 343-345 -
Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
Nousiainen T, Jantunen E, Vanninen E, Remes J, Vuolteenaho O, Hartikainen J. 1999. European journal of haematology. 62: 135-141 -
QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma
Nousiainen T, Vanninen E, Rantala A, Jantunen E, Hartikainen J. 1999. Journal of internal medicine. 245: 359-364 -
Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients
Nousiainen T, Jantunen E, Vanninen E, Remes J, Puustinen J, Rantala A, Vuolteenaho O, Hartikainen J. 1998. European journal of haematology. 61: 347-353 -
Interferonit veritautien hoidossa
Jantunen E, Nousiainen T. 1998. Duodecim. 114: 1240-1247 -
Kantasolujen siirrot reumataudeissa
Jantunen E, Myllykangas-Luosujärvi R. 1998. Duodecim -
Reumapotilaiden metotreksaattihoidon vakavat haittavaikutukset
Purokivi M, Myllykangas-Luosujärvi R, Jantunen E. 1998. Duodecim. 114: 2187-2190 -
Alkuvaiheen kokemuksia veren kantasolujen siirroista KYS:ssa
Jantunen E, Paakkunainen P, Nousiainen T, Riikonen P, Voutilainen L, Mahlamäki E. 1997. Lääkärilehti. 52: 205-207 -
Incidence and risk factors for invasive fungal infektions in allogeneic BMT recipients
Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kähkölä P, Ruutu T. 1997. Bone marrow transplantation. 19: 801-808 -
Antrasykliinihoidon sydänhaitat
Jantunen E, Remes J, Vanninen E, Riikonen P, Nousiainen T. 1996. Duodecim. 112: 1274-1280 -
Bisfosfonaattien kliininen käyttö
Jantunen E, Niskanen L. 1996. Lääkärilehti. 51: 2449-2454 -
Bisphosphonate therapy in multiple myeloma
Laakso M, Jantunen E. 1996. Acta oncologica. 35: 55-56 -
Bisphosphonates in multiple myeloma: current status: future perspectives
Jantunen E, Laakso M. 1996. British journal of haematology. 93: 501-506 -
Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation after allogeneic bone marrow transplantation
Jantunen E, Kolho E, Ruutu P, Koukila-Kähkölä P, Virolainen M, Juvonen E, Volin L. 1996. Bone marrow transplantation. 18: 229-230 -
Pulsed dexamethasone for refractory idiopathic thrombocytopenic purpura
Jantunen E, Nousiainen T. 1996. American journal of hematology -
Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies
Kaipiainen-Seppänen O, Jantunen E, Kuusisto J, Marin S. 1996. Journal of rheumatology. 23: 779-781 -
Trombosytopeniat
Nieminen U, Jantunen E. Teoksessa: Ruutu T, Rajamäki A, Krusius T(toim.) , 1996. Veritaudit. s. 422-432. Duodecim -
Burkittin leukemia-lymfooma
Jantunen E, Vornanen M, Nousiainen T, Riikonen P. 1995. Duodecim. 111: 2115-2121 -
Klodronaatti ja myelooma
Jantunen E, Lahtinen R, Laakso M. 1995. Duodecim. 111: 1085-1087 -
Use of clodronate in multiple myeloma
Jantunen E, Lahtinen R, Laakso M. 1995. Leukemia & lymphoma. 19: 207-211 -
Von Willebrandin tauti ja trombopatiat
Kekomäki R, Jantunen E. Teoksessa: Leikola J, Myllylä G(toim.) , 1995. Verensiirrot. s. 287-295. Duodecim